Ten Medicare Advantage Insurers Now Suing Over 2027 Star Ratings as Seniors Weigh Plans Before December 7 Deadline
Ten Medicare Advantage insurers, including CVS Health, Centene, and Elevance Health, have sued the federal government over their 2027 star ratings. They argue CMS used unauthorized quality measures, with CVS estimating a $2B impact in 2028. Star ratings influence bonus payments and plan rebates, affecting benefits. Open enrollment ends Dec. 7, 2026.
How this was made

The 30-second read
Why it matters
The lawsuits introduce regulatory risk and uncertainty around future quality bonus payments, which could affect insurer valuations ahead of the Dec. 7 enrollment deadline.
Market read
The litigation could pressure U.S. health‑insurance stocks as investors assess potential bonus payment reductions before the enrollment deadline.
What to watch
The outcome of the Clover Health precedent and possible CMS rule changes could mitigate the lawsuits' impact.
Background
A growing coalition of Medicare Advantage insurers is suing CMS over the methodology of 2027 star ratings, citing potential billions in lost bonus payments.
Ticker impact
CVS Health claims lower 2027 star ratings could cut its 2028 bonus payments by about $2 billion, prompting its lawsuit.
likely pressure as the market prices in the $2 billion bonus hit risk
The lawsuit directly ties a large financial hit to the star rating dispute, creating material uncertainty.
Centene says it could lose $448 million from the star‑rating dispute and faces low‑performance warnings.
moderate pressure from the disclosed $448 million potential loss
The disclosed loss figure is sizable but smaller than CVS's, suggesting a less severe impact.
Elevance Health is listed among the insurers suing over the 2027 star ratings, indicating exposure to the same regulatory risk.
possible slight pressure due to litigation exposure
No specific loss amount disclosed for Elevance, so impact is less certain.
Market effects
Medicare Advantage insurers may see heightened regulatory scrutiny and potential adjustments to quality bonus structures.
U.S. health‑insurance sector could experience modest volatility ahead of open enrollment.
Limited to U.S. healthcare markets; no direct global spillover.
Counterpoint
If courts limit CMS's authority, insurers could retain higher bonus payments, potentially boosting stocks.
Key entities
- companyCVS Health
U.S. pharmacy and health‑services company filing lawsuit over star ratings.
- companyCentene
Managed‑care insurer estimating $448 million loss from rating dispute.
- companyElevance Health
Health‑insurance firm joining the litigation group.


